During secondary infection, sub-neutralizing antibodies form infectious immune-complexes with DENV, resulting in higher levels of viral progeny in FcγR-expressing cells, a phenomenon known as antibody-dependent enhancement (ADE) [22], [23]. The gene discussed is FCGR2A; the disease is infection.